The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Arteriovenous (Av) Fistula Needle Market Research Report 2024
Synopsis
AV Fistula Needle is a connection of artery to vein. The arteriovenous fistula needle is recommended as the first choice for hemodialysis. Arteriovenous fistula needles are used in conjunction with a connector of hemodialysis blood tubing set. These needles connect blood lines to the blood vessel through during dialysis procedure via an internal fistula. Health care providers recommend an arteriovenous fistula needle due to its good blood flow for dialysis, long lasting than other types of access, safety and less possibility of getting infected and blood clotting.
The global Arteriovenous (Av) Fistula Needle market was valued at US$ 186 million in 2023 and is anticipated to reach US$ 241.1 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Global A.V. Fistula Needles key players include Nipro, Fresenius, B. Braun, Kawasumi Lab, Asahi Kasei, etc. Global top five manufacturers hold a share about 65%. North America and Europe is the largest market, both with a share about 35%, followed by Asia Pacific, with a share about 20 percent. In terms of application, the largest application is Dialysis Center, followed by Home Dialysis, etc.
This report aims to provide a comprehensive presentation of the global market for Arteriovenous (Av) Fistula Needle, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arteriovenous (Av) Fistula Needle.
Report Scope
The Arteriovenous (Av) Fistula Needle market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Arteriovenous (Av) Fistula Needle market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Arteriovenous (Av) Fistula Needle manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nipro
Fresenius
B. Braun
Kawasumi Lab
Asahi Kasei
JMS
Bain Medical
Farmasol
Tianjin Pharma
Hongda Medical
Baihe Medical
Far East Medical
Hemoclean
Segment by Type
15 Gauge
16 Gauge
17 Gauge
Other
Segment by Application
Dialysis Center
Home Dialysis
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Arteriovenous (Av) Fistula Needle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Arteriovenous (Av) Fistula Needle in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
AV Fistula Needle is a connection of artery to vein. The arteriovenous fistula needle is recommended as the first choice for hemodialysis. Arteriovenous fistula needles are used in conjunction with a connector of hemodialysis blood tubing set. These needles connect blood lines to the blood vessel through during dialysis procedure via an internal fistula. Health care providers recommend an arteriovenous fistula needle due to its good blood flow for dialysis, long lasting than other types of access, safety and less possibility of getting infected and blood clotting.
The global Arteriovenous (Av) Fistula Needle market was valued at US$ 186 million in 2023 and is anticipated to reach US$ 241.1 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Global A.V. Fistula Needles key players include Nipro, Fresenius, B. Braun, Kawasumi Lab, Asahi Kasei, etc. Global top five manufacturers hold a share about 65%. North America and Europe is the largest market, both with a share about 35%, followed by Asia Pacific, with a share about 20 percent. In terms of application, the largest application is Dialysis Center, followed by Home Dialysis, etc.
This report aims to provide a comprehensive presentation of the global market for Arteriovenous (Av) Fistula Needle, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arteriovenous (Av) Fistula Needle.
Report Scope
The Arteriovenous (Av) Fistula Needle market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Arteriovenous (Av) Fistula Needle market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Arteriovenous (Av) Fistula Needle manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nipro
Fresenius
B. Braun
Kawasumi Lab
Asahi Kasei
JMS
Bain Medical
Farmasol
Tianjin Pharma
Hongda Medical
Baihe Medical
Far East Medical
Hemoclean
Segment by Type
15 Gauge
16 Gauge
17 Gauge
Other
Segment by Application
Dialysis Center
Home Dialysis
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Arteriovenous (Av) Fistula Needle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Arteriovenous (Av) Fistula Needle in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Arteriovenous (Av) Fistula Needle Market Overview
1.1 Product Overview and Scope of Arteriovenous (Av) Fistula Needle
1.2 Arteriovenous (Av) Fistula Needle Segment by Type
1.2.1 Global Arteriovenous (Av) Fistula Needle Market Value Comparison by Type (2024-2030)
1.2.2 15 Gauge
1.2.3 16 Gauge
1.2.4 17 Gauge
1.2.5 Other
1.3 Arteriovenous (Av) Fistula Needle Segment by Application
1.3.1 Global Arteriovenous (Av) Fistula Needle Market Value by Application: (2024-2030)
1.3.2 Dialysis Center
1.3.3 Home Dialysis
1.3.4 Other
1.4 Global Arteriovenous (Av) Fistula Needle Market Size Estimates and Forecasts
1.4.1 Global Arteriovenous (Av) Fistula Needle Revenue 2019-2030
1.4.2 Global Arteriovenous (Av) Fistula Needle Sales 2019-2030
1.4.3 Global Arteriovenous (Av) Fistula Needle Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Arteriovenous (Av) Fistula Needle Market Competition by Manufacturers
2.1 Global Arteriovenous (Av) Fistula Needle Sales Market Share by Manufacturers (2019-2024)
2.2 Global Arteriovenous (Av) Fistula Needle Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Arteriovenous (Av) Fistula Needle Average Price by Manufacturers (2019-2024)
2.4 Global Arteriovenous (Av) Fistula Needle Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Arteriovenous (Av) Fistula Needle, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Arteriovenous (Av) Fistula Needle, Product Type & Application
2.7 Arteriovenous (Av) Fistula Needle Market Competitive Situation and Trends
2.7.1 Arteriovenous (Av) Fistula Needle Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Arteriovenous (Av) Fistula Needle Players Market Share by Revenue
2.7.3 Global Arteriovenous (Av) Fistula Needle Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Arteriovenous (Av) Fistula Needle Retrospective Market Scenario by Region
3.1 Global Arteriovenous (Av) Fistula Needle Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Arteriovenous (Av) Fistula Needle Global Arteriovenous (Av) Fistula Needle Sales by Region: 2019-2030
3.2.1 Global Arteriovenous (Av) Fistula Needle Sales by Region: 2019-2024
3.2.2 Global Arteriovenous (Av) Fistula Needle Sales by Region: 2025-2030
3.3 Global Arteriovenous (Av) Fistula Needle Global Arteriovenous (Av) Fistula Needle Revenue by Region: 2019-2030
3.3.1 Global Arteriovenous (Av) Fistula Needle Revenue by Region: 2019-2024
3.3.2 Global Arteriovenous (Av) Fistula Needle Revenue by Region: 2025-2030
3.4 North America Arteriovenous (Av) Fistula Needle Market Facts & Figures by Country
3.4.1 North America Arteriovenous (Av) Fistula Needle Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Arteriovenous (Av) Fistula Needle Sales by Country (2019-2030)
3.4.3 North America Arteriovenous (Av) Fistula Needle Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Arteriovenous (Av) Fistula Needle Market Facts & Figures by Country
3.5.1 Europe Arteriovenous (Av) Fistula Needle Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Arteriovenous (Av) Fistula Needle Sales by Country (2019-2030)
3.5.3 Europe Arteriovenous (Av) Fistula Needle Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Arteriovenous (Av) Fistula Needle Market Facts & Figures by Country
3.6.1 Asia Pacific Arteriovenous (Av) Fistula Needle Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Arteriovenous (Av) Fistula Needle Sales by Country (2019-2030)
3.6.3 Asia Pacific Arteriovenous (Av) Fistula Needle Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Arteriovenous (Av) Fistula Needle Market Facts & Figures by Country
3.7.1 Latin America Arteriovenous (Av) Fistula Needle Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Arteriovenous (Av) Fistula Needle Sales by Country (2019-2030)
3.7.3 Latin America Arteriovenous (Av) Fistula Needle Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Arteriovenous (Av) Fistula Needle Market Facts & Figures by Country
3.8.1 Middle East and Africa Arteriovenous (Av) Fistula Needle Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Arteriovenous (Av) Fistula Needle Sales by Country (2019-2030)
3.8.3 Middle East and Africa Arteriovenous (Av) Fistula Needle Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Arteriovenous (Av) Fistula Needle Sales by Type (2019-2030)
4.1.1 Global Arteriovenous (Av) Fistula Needle Sales by Type (2019-2024)
4.1.2 Global Arteriovenous (Av) Fistula Needle Sales by Type (2025-2030)
4.1.3 Global Arteriovenous (Av) Fistula Needle Sales Market Share by Type (2019-2030)
4.2 Global Arteriovenous (Av) Fistula Needle Revenue by Type (2019-2030)
4.2.1 Global Arteriovenous (Av) Fistula Needle Revenue by Type (2019-2024)
4.2.2 Global Arteriovenous (Av) Fistula Needle Revenue by Type (2025-2030)
4.2.3 Global Arteriovenous (Av) Fistula Needle Revenue Market Share by Type (2019-2030)
4.3 Global Arteriovenous (Av) Fistula Needle Price by Type (2019-2030)
5 Segment by Application
5.1 Global Arteriovenous (Av) Fistula Needle Sales by Application (2019-2030)
5.1.1 Global Arteriovenous (Av) Fistula Needle Sales by Application (2019-2024)
5.1.2 Global Arteriovenous (Av) Fistula Needle Sales by Application (2025-2030)
5.1.3 Global Arteriovenous (Av) Fistula Needle Sales Market Share by Application (2019-2030)
5.2 Global Arteriovenous (Av) Fistula Needle Revenue by Application (2019-2030)
5.2.1 Global Arteriovenous (Av) Fistula Needle Revenue by Application (2019-2024)
5.2.2 Global Arteriovenous (Av) Fistula Needle Revenue by Application (2025-2030)
5.2.3 Global Arteriovenous (Av) Fistula Needle Revenue Market Share by Application (2019-2030)
5.3 Global Arteriovenous (Av) Fistula Needle Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Nipro
6.1.1 Nipro Corporation Information
6.1.2 Nipro Description and Business Overview
6.1.3 Nipro Arteriovenous (Av) Fistula Needle Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Nipro Arteriovenous (Av) Fistula Needle Product Portfolio
6.1.5 Nipro Recent Developments/Updates
6.2 Fresenius
6.2.1 Fresenius Corporation Information
6.2.2 Fresenius Description and Business Overview
6.2.3 Fresenius Arteriovenous (Av) Fistula Needle Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Fresenius Arteriovenous (Av) Fistula Needle Product Portfolio
6.2.5 Fresenius Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Corporation Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Arteriovenous (Av) Fistula Needle Sales, Revenue and Gross Margin (2019-2024)
6.3.4 B. Braun Arteriovenous (Av) Fistula Needle Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Kawasumi Lab
6.4.1 Kawasumi Lab Corporation Information
6.4.2 Kawasumi Lab Description and Business Overview
6.4.3 Kawasumi Lab Arteriovenous (Av) Fistula Needle Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kawasumi Lab Arteriovenous (Av) Fistula Needle Product Portfolio
6.4.5 Kawasumi Lab Recent Developments/Updates
6.5 Asahi Kasei
6.5.1 Asahi Kasei Corporation Information
6.5.2 Asahi Kasei Description and Business Overview
6.5.3 Asahi Kasei Arteriovenous (Av) Fistula Needle Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Asahi Kasei Arteriovenous (Av) Fistula Needle Product Portfolio
6.5.5 Asahi Kasei Recent Developments/Updates
6.6 JMS
6.6.1 JMS Corporation Information
6.6.2 JMS Description and Business Overview
6.6.3 JMS Arteriovenous (Av) Fistula Needle Sales, Revenue and Gross Margin (2019-2024)
6.6.4 JMS Arteriovenous (Av) Fistula Needle Product Portfolio
6.6.5 JMS Recent Developments/Updates
6.7 Bain Medical
6.6.1 Bain Medical Corporation Information
6.6.2 Bain Medical Description and Business Overview
6.6.3 Bain Medical Arteriovenous (Av) Fistula Needle Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bain Medical Arteriovenous (Av) Fistula Needle Product Portfolio
6.7.5 Bain Medical Recent Developments/Updates
6.8 Farmasol
6.8.1 Farmasol Corporation Information
6.8.2 Farmasol Description and Business Overview
6.8.3 Farmasol Arteriovenous (Av) Fistula Needle Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Farmasol Arteriovenous (Av) Fistula Needle Product Portfolio
6.8.5 Farmasol Recent Developments/Updates
6.9 Tianjin Pharma
6.9.1 Tianjin Pharma Corporation Information
6.9.2 Tianjin Pharma Description and Business Overview
6.9.3 Tianjin Pharma Arteriovenous (Av) Fistula Needle Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Tianjin Pharma Arteriovenous (Av) Fistula Needle Product Portfolio
6.9.5 Tianjin Pharma Recent Developments/Updates
6.10 Hongda Medical
6.10.1 Hongda Medical Corporation Information
6.10.2 Hongda Medical Description and Business Overview
6.10.3 Hongda Medical Arteriovenous (Av) Fistula Needle Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hongda Medical Arteriovenous (Av) Fistula Needle Product Portfolio
6.10.5 Hongda Medical Recent Developments/Updates
6.11 Baihe Medical
6.11.1 Baihe Medical Corporation Information
6.11.2 Baihe Medical Arteriovenous (Av) Fistula Needle Description and Business Overview
6.11.3 Baihe Medical Arteriovenous (Av) Fistula Needle Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Baihe Medical Arteriovenous (Av) Fistula Needle Product Portfolio
6.11.5 Baihe Medical Recent Developments/Updates
6.12 Far East Medical
6.12.1 Far East Medical Corporation Information
6.12.2 Far East Medical Arteriovenous (Av) Fistula Needle Description and Business Overview
6.12.3 Far East Medical Arteriovenous (Av) Fistula Needle Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Far East Medical Arteriovenous (Av) Fistula Needle Product Portfolio
6.12.5 Far East Medical Recent Developments/Updates
6.13 Hemoclean
6.13.1 Hemoclean Corporation Information
6.13.2 Hemoclean Arteriovenous (Av) Fistula Needle Description and Business Overview
6.13.3 Hemoclean Arteriovenous (Av) Fistula Needle Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hemoclean Arteriovenous (Av) Fistula Needle Product Portfolio
6.13.5 Hemoclean Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Arteriovenous (Av) Fistula Needle Industry Chain Analysis
7.2 Arteriovenous (Av) Fistula Needle Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Arteriovenous (Av) Fistula Needle Production Mode & Process
7.4 Arteriovenous (Av) Fistula Needle Sales and Marketing
7.4.1 Arteriovenous (Av) Fistula Needle Sales Channels
7.4.2 Arteriovenous (Av) Fistula Needle Distributors
7.5 Arteriovenous (Av) Fistula Needle Customers
8 Arteriovenous (Av) Fistula Needle Market Dynamics
8.1 Arteriovenous (Av) Fistula Needle Industry Trends
8.2 Arteriovenous (Av) Fistula Needle Market Drivers
8.3 Arteriovenous (Av) Fistula Needle Market Challenges
8.4 Arteriovenous (Av) Fistula Needle Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
